Mount Sinai, USA

Amaia Lujambio

Her research focuses on how genetic and epigenetic alterations contribute to tumorigenesis, alter treatment response, and create vulnerabilities that may be targeted therapeutically. Furthermore, she is also interested in understanding the role of cellular senescence in liver cancer initiation.